Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001846487-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | 2026-02-12 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $76.55 | -7,032 | 92.6K | -7% | -$538.3K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $76.98 | -5,576 | 90.2K | -6% | -$429.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | S | D | 7,032 | $76.55 | 92,566 | D | — | — | (F3) The shares were sold in multiple trades at prices ranging from $75.43 to $76.92. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2026-02-12 | F | D | 3,173 | $76.70 | 99,598 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-14 | F | D | 2,403 | $77.36 | 90,163 | D | — | — |